Profile data is unavailable for this security.
About the company
Scandion Oncology A/S is a manufacturer of biological products. The Company was founded in May 2017 and is located in Copenhagen, Denmark. It focuses on modern onclogy, the treatment of cancers that have developed resistance to chemotherapy.
- Revenue in SEK (TTM)0.00
- Net income in SEK-61.41m
- Incorporated2017
- Employees4.00
- LocationScandion Oncology A/SFruebjergvej 3, Koebenhavn OeKOEBENHAVN 2100DenmarkDNK
- Websitehttps://scandiononcology.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NextCell Pharma AB | 12.45m | -39.37m | 41.77m | -- | -- | 0.7481 | -- | 3.36 | -1.15 | -1.15 | 0.3621 | 1.62 | 0.1406 | 14.06 | 7.20 | -- | -44.45 | -34.92 | -50.09 | -37.06 | 12.04 | -68.21 | -316.25 | -538.60 | 4.36 | -- | 0.00 | -- | 80.96 | 72.85 | -15.21 | -- | -- | -- |
Oncozenge AB | 0.00 | -15.90m | 44.51m | -- | -- | 2.39 | -- | -- | -1.36 | -1.36 | 0.00 | 1.59 | 0.00 | -- | -- | -- | -55.57 | -- | -60.45 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 65.91 | -- | -- | -- |
Diagonal Bio AB | 23.00k | -11.68m | 44.58m | 4.00 | -- | 0.2037 | -- | 1,938.30 | -0.1982 | -0.1982 | 0.0004 | 0.3221 | 0.0007 | -- | 2.00 | 5,750.00 | -37.35 | -- | -44.49 | -- | -41,604.35 | -- | -50,769.57 | -- | 0.5105 | -104.20 | -- | -- | -88.67 | -- | 27.75 | -- | -- | -- |
Veg of Lund AB (publ) | 4.82m | -19.91m | 44.98m | 7.00 | -- | 1.07 | -- | 9.34 | -0.7328 | -0.7328 | 0.1519 | 1.01 | 0.1337 | 13.74 | 14.40 | 688,000.00 | -55.27 | -129.03 | -82.56 | -209.20 | -384.61 | -781.09 | -413.50 | -923.73 | 0.1256 | -12.90 | 0.1405 | -- | 89.57 | 39.87 | 56.02 | -- | -12.47 | -- |
Klaria Pharma Holding AB (publ) | 0.00 | -18.39m | 48.14m | 5.00 | -- | 1.17 | -- | -- | -0.1824 | -0.355 | 0.00 | 0.3862 | 0.00 | -- | -- | 0.00 | -19.03 | -37.28 | -31.28 | -51.56 | -- | -- | -- | -2,077.34 | -- | -3.88 | 0.00 | -- | -100.00 | -- | 71.17 | -- | -- | -- |
Alzinova AB | 270.00k | -16.48m | 52.37m | -- | -- | 0.46 | -- | 193.96 | -0.4149 | -0.4149 | 0.0067 | 2.56 | 0.0023 | -- | 0.3671 | -- | -14.04 | -10.77 | -14.91 | -11.27 | 7,360.55 | -- | -6,103.69 | -18,447.90 | -- | -- | 0.007 | -- | -- | -- | -25.92 | -- | 15.81 | -- |
SoftOx Solutions AS | 6.97m | -42.04m | 53.68m | -- | -- | -- | -- | 7.70 | -1.98 | -1.98 | 0.3286 | -0.0127 | 0.081 | -- | 1.60 | -- | -48.81 | -50.83 | -82.20 | -64.58 | -- | -- | -602.91 | -646.67 | 0.1745 | -3.45 | -- | -- | -1.88 | 10.06 | 40.85 | -- | 39.43 | -- |
Scandion Oncology A/S | 0.00 | -61.41m | 56.99m | 4.00 | -- | 1.17 | -- | -- | -1.53 | -1.53 | 0.00 | 1.20 | 0.00 | -- | -- | 0.00 | -63.25 | -45.09 | -76.67 | -52.65 | -- | -- | -- | -- | -- | -- | 0.0158 | -- | -- | -- | 48.89 | -- | -- | -- |
Pila Pharma AB | 1.46m | -9.93m | 58.06m | 1.00 | -- | 8.72 | -- | 39.68 | -0.5304 | -0.5304 | 0.0767 | 0.28 | 0.1513 | -- | 6.11 | 1,463,020.00 | -102.68 | -108.88 | -122.66 | -121.45 | -127.88 | -42.67 | -678.73 | -1,577.64 | -- | -159.47 | 0.104 | -- | -22.21 | -- | 62.92 | -- | -- | -- |
Orphazyme A/S | 0.00 | -40.80m | 58.47m | 1.00 | -- | 2.62 | -- | -- | -737.75 | -737.75 | 0.00 | 403.34 | 0.00 | -- | -- | 0.00 | -68.42 | -76.08 | -94.18 | -105.34 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 32.00 | -- | -- | -- |
PCI Biotech Holding ASA | 2.99m | -20.29m | 58.84m | 7.00 | -- | 1.51 | -- | 19.70 | -0.5443 | -0.5443 | 0.0801 | 1.05 | 0.0556 | -- | 0.6848 | 427,142.80 | -37.78 | -36.44 | -41.97 | -40.14 | -- | -- | -679.43 | -1,055.43 | -- | -- | 0.0081 | -- | -37.05 | -20.78 | 63.13 | -- | -- | -- |
Spago Nanomedical AB (publ) | 1.47m | -34.41m | 61.80m | 12.00 | -- | 1.80 | -- | 42.18 | -0.2454 | -0.2454 | 0.0107 | 0.1525 | 0.0324 | -- | 9.90 | 112,692.30 | -76.02 | -20.19 | -90.21 | -20.97 | 115.84 | -- | -2,349.01 | -4,853.45 | -- | -- | 0.00 | -- | 14.14 | -- | -7.72 | -- | -- | -- |
Combigene AB | 5.54m | -35.67m | 67.92m | 8.00 | -- | 0.5832 | -- | 12.25 | -1.80 | -1.80 | 0.28 | 5.88 | 0.0398 | -- | 2.63 | 693,015.00 | -25.58 | -13.00 | -26.56 | -14.58 | -- | -- | -643.32 | -58.77 | -- | -- | 0.00 | -- | -79.23 | 268.58 | -479.27 | -- | -24.02 | -- |
ViroGates A/S | 8.98m | -19.97m | 68.28m | 10.00 | -- | 3.25 | -- | 7.60 | -6.00 | -6.00 | 1.44 | 2.08 | 0.3344 | 0.316 | 3.64 | 573,300.00 | -74.36 | -46.58 | -80.05 | -52.09 | 77.20 | 77.91 | -222.40 | -238.01 | 10.45 | -19.08 | 0.2833 | -- | -45.01 | 10.98 | -25.40 | -- | -- | -- |
Immunovia AB (publ) | 1.21m | -260.73m | 69.02m | 11.00 | -- | 1.58 | -- | 56.95 | -6.06 | -6.06 | 0.0276 | 0.9648 | 0.0075 | 58.23 | 14.96 | 110,181.80 | -160.93 | -41.33 | -194.89 | -44.24 | -5,523.76 | -7,553.76 | -21,512.13 | -20,879.29 | 2.03 | -- | 0.1675 | -- | 37.55 | 36.48 | -84.09 | -- | -50.93 | -- |
Prolight Diagnostics AB (publ) | 0.00 | -135.46m | 69.97m | 16.00 | -- | 0.3651 | -- | -- | -0.4074 | -0.4074 | 0.00 | 0.3835 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -13.84 | -- |
Data as of May 15 2024. Currency figures normalised to Scandion Oncology A/S's reporting currency: Swedish Krona SEK